Opioid Use Disorder (OUD) is a chronic medical condition characterized by a problematic pattern of opioid use that leads to significant impairment or distress.
It is classified as a substance use disorder in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) and is recognized by major health authorities, including the American Psychiatric Association and the World Health Organization, as a treatable neurobiological disorder rather than a moral failing or a matter of willpower.
OUD can involve prescription opioids (such as oxycodone, hydrocodone, morphine, or fentanyl prescribed for pain) as well as illicit opioids (such as heroin or illegally manufactured fentanyl) and currently, supplements that can be purchased from a gas station KRatom, 7-OH) The disorder exists on a spectrum from mild to severe, and it can affect anyone regardless of age, background, or how the opioid use began.
Key Takeaways
- OUD is a diagnosable, treatable medical condition, not a character flaw.
- It exists on a spectrum and is diagnosed using specific clinical criteria.
- Medication combined with behavioral therapy is the most effective treatment approach.
- Recovery is possible, and many people with OUD go on to lead full, stable lives with proper support.
- Our health is not a choice, however, we do often have agency in our thought process and our behavior with some assistance and training. I have never met a person struggling with OUD that would want this potentially fatal disorder.
How Is OUD Diagnosed?
Opioid Use Disorder (OUD) is diagnosed using specific criteria from the Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR). Healthcare providers, such as doctors or mental health professionals, assess a person’s behavior over a 12-month period.
The diagnosis isn’t based on a single biological test or drug screen. Instead, it relies on identifying a problematic pattern of opioid use that leads to clinical impairment or distress.
The DSM-5 Criteria: To be diagnosed with OUD, a person must meet at least 2 of the following 11 criteria within a 1 year window. A simple way to look at this is the three C’s of addiction; Cravings, lack of control, and consequences associated with use.
Lack of Control
- Taking opioids in larger amounts or over a longer period than intended.
- Having a persistent desire or making unsuccessful efforts to cut down or control use.
- Spending a great deal of time obtaining, using, or recovering from the effects of opioids.
- Experiencing cravings, or a strong desire/urge to use opioids.
Consequences: Social & Operational Impairment
- Failing to fulfill major role obligations at work, school, or home due to use.
- Continuing use despite persistent social or interpersonal problems caused or worsened by the drug.
- Giving up or reducing important social, occupational, or recreational activities because of use.
Lack of Control
- Using opioids in situations where it is physically hazardous (e.g., driving under the influence).
- Continuing use despite knowing it causes or worsens a persistent physical or psychological problem.
Pharmacological Indicators
- Tolerance: Needing a markedly increased dose to achieve intoxication or the desired effect, or experiencing a markedly diminished effect with the same dose.
- Withdrawal: Experiencing the characteristic opioid withdrawal syndrome, or taking opioids (or a closely related substance) to relieve or avoid withdrawal symptoms.
Important Note on Tolerance and Withdrawal: Criteria 10 and 11 do not count toward a diagnosis of OUD if the individual is taking opioids strictly under legitimate, appropriate medical supervision (such as long-term pain management). Habituation and dependence to opioids is unfortunately predictable, anyone on chronic opioid treatment will typically require increased dosage over time to maintain the same therapeutic outcome. If they go without their opioids, they will go into withdrawal and feel miserable.
OUD is not just the physical dependency on opioids, it includes significant functional impairment of the life; the substance causes disorder for the individual.
Severity Levels
Once a diagnosis is made, clinicians categorize the severity based on how many criteria are met:
- Mild: 2 to 3 criteria met.
- Moderate: 4 to 5 criteria met.
- Severe: 6 or more criteria met.
The Assessment Process
A formal diagnosis typically involves a comprehensive clinical interview. Providers look at the full picture, which includes:
- A thorough medical and psychiatric history.
- Self-reported substance use patterns.
- Collateral information (with permission) from family members or medical records.
- Urine drug screenings or physical exams (used to detect current substance use or manage safety, though they do not diagnose the disorder on their own).
What Causes Opioid Use Disorder?
OUD develops through a combination of factors rather than a single cause:
- Biological factors: Genetics account for an estimated 40–60% of a person’s vulnerability to substance use disorders. Opioids also physically alter brain circuitry involved in reward, stress, and self-control over time.
- Exposure and access: Prolonged use of prescription opioids for pain management is one of the most common pathways into OUD.
- Psychological factors: Co-occurring mental health conditions, such as depression, anxiety, or PTSD, increase risk.
- Environmental and social factors: Trauma, chronic stress, lack of social support, adverse childhood events, and easy access to opioids all contribute.
Signs and Symptoms of OUD
Common signs include:
- Using opioids in larger doses or more frequently than prescribed
- Doctor shopping or seeking multiple prescriptions
- Withdrawal from social activities and relationships
- Neglecting responsibilities at work, school, or home
- Physical signs such as drowsiness, constricted pupils, or slowed breathing
- Withdrawal symptoms (nausea, muscle aches, anxiety, sweating) when not using
- Continuing use despite negative health, legal, or financial consequences
How Is OUD Treated?
OUD is a chronic, relapsing and remitting condition. condition, similar in some ways to diabetes or hypertension — it often requires ongoing management rather than a one-time fix. The most effective, evidence-based approach combines medication with behavioral support.
Chronic diseases can flare during times of stress, trauma, physical unwellness, environmental disaster. This can unfortunately sometimes result in a return to or recurrence of opioid use in someone who has otherwise stable. This can be quite risky, especially if someone has been off opioids entirely, as returning to use the individual no longer has a tolerance to the opioids, This is unfortunately when fatal overdoses can occur. It’s important to always practice harm reduction, increase the availability of Narcan, and thoroughly counsel on the risk of recurrence.
Medications for Opioid Use Disorder (MOUD) Three medications are FDA-approved and considered the gold standard of care:
Methadone
Methadone is a long-acting opioid agonist that reduces cravings and withdrawal without producing a strong high, dispensed through specialized clinics. Methadone is complex as there is significant variable metabolism between individuals, so the final drug level in the body can vary quite a bit in-between individuals.
As Methadone is a full opioid agonist, there is a significantly higher risk of fatal respiratory depression in the setting of overdose or polypharmacy associated with Methadone. Additionally, Methadone can cause significant QTc prolongation, which can result in a fatal arrhytmia if the QTc interval is prolonged too long.
This is especially important due to the high incide43nce of cormborbid substance use disroder and mental health disorders, and many mental health medications also prolong the QTc interval. Risk is dependent on current medication regimen, age, genetics, medical history, and overall frailty. This can be mitigated by ECG monitoring as needed.
Methadone, being a full opioid agonist, can be more effective than Suboxone for folks who need additional support. Unfortunately, due to federal regulations, methadone for OUD can only be rpescribed in the setting of an opioid treatment program. These often require much more frequent visits than a typical outpatient practice setting.
Buprenorphine
Buprenorphine (often combined with naloxone, e.g., Suboxone) is a partial opioid agonist that can be prescribed in office-based settings. Suboxone has a ceiling on respiratory depression, and it is incredibly unlikely for fatal respiratory depression to occur on suboxone alone with no other central nervous system / respiratory depressants on suboxone alone.
Naltrexone
Naltrexone (e.g., Vivitrol) is an opioid antagonist that blocks the effects of opioids entirely
Research consistently shows that MOUD reduces overdose deaths, illicit opioid use, and infectious disease transmission, and improves retention in treatment compared to abstinence-only approaches. The longer an individual is engaged in treatment, the lower their risk of overdose and death.
RISK OF OVERDOSE / DEATH with Suboxone vs Suboxone with additional substances
Results:
Among 11,764 drug-related deaths, only 564 (4.8%) involved buprenorphine. Buprenorphine alone was present in 32 deaths, of which 20 were considered the direct cause of death (0.2% of all drug-related deaths). Significantly more BIDs involved five or more drugs (23%) compared with other opioid deaths (14.9%). Co-intoxicants found most frequently in BIDs were benzodiazepines (47.3%), methamphetamine (27.1%), and fentanyl (22.9%). Cardiovascular and pulmonary comorbidities were identified in 43% and 21% of BIDs, respectively. Of the 564 BIDs, a current buprenorphine prescription was present in 132 deaths (23.4%).
Conclusions:
Despite increasing buprenorphine use, BIDs comprised less than 5% of overall West Virginia drug-related deaths. Seldom was it the only drug found, and most decedents did not have current prescriptions for buprenorphine. Although buprenorphine is effective, with a wide safety margin, clinicians and patients should be aware that buprenorphine can be involved in overdose deaths, especially when buprenorphine is taken in combination with drugs such as benzodiazepines, methamphetamine, or fentanyl, and in persons with underlying cardiovascular or pulmonary comorbidities.
J Stud Alcohol Drugs. 2023 Feb 19;84(1):171–179. doi: 10.15288/jsad.22-00049
Is OUD the Same as Physical Dependence?
No. Physical dependence — experiencing withdrawal symptoms when a medication is stopped — can occur in anyone taking opioids for a prolonged period, even exactly as prescribed by a doctor. OUD, by contrast, involves a broader pattern of compulsive use, loss of control, and continued use despite harm. A person can be physically dependent without having OUD.
Why Language Matters
Health organizations increasingly recommend person-first language — saying “a person with opioid use disorder” rather than “an addict” or “a drug abuser.” Research shows that stigmatizing language can affect how even clinicians perceive and treat patients, and can discourage people from seeking help.
Personally, I try to use the language my patients use, as long as my patient is aware that I am coming to the table with the goals of mutual respect, harm reduction, and figuring out a plan that will work with their lifestyle.
This does not mean I don’t disagree with my patients. Their is a lot of responsibility with prescribing medications for opioid use disorder, including that if these medications are prescribed with additional respiratory depressants they can lead to overdose and death.
